eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TrxR↓, AntiCan↑, TumCG↓, Apoptosis↑, necrosis↑, cl‑PARP↑, MMP↓, ROS↑, GSH↓, eff↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Colon, |
HCT15 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
TrxR↓, eff↓, eff↓, other∅,
PI3K↓, p‑Akt↓, ROS↑, TumCCA↑, p27↑, P21↑, mt-Apoptosis↑, BAD↑, Casp9↑, MMP↓, eff↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
TumAuto↑, ROS↑, eff↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HaCaT |
|
|
|
DNAdam↑, Apoptosis↑, ChemoSen↑, ROS↑, mt-ROS↑, Casp↑, Casp3↑, selectivity↑, TumCP↓, tumCV↓, eff↓,
TumCG↓, ROS↑, Apoptosis↑, MMP↓, DNAdam↑, Cyt‑c↑, AIF↑, Casp3↑, Casp9↑, eff↓,
AntiCan↑, TrxR1↓, TrxR2↓, ROS↑, Apoptosis↑, eff↓, eff↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
1321N1 |
|
|
|
*ROS↓, *BioAv↑, LC3II↑, LAMP1?, TumAuto↑, TFEB↑, ROS↑, eff↓,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Nor, |
SVGp12 |
|
|
|
Ferroptosis↑, xCT↓, GSH↓, GPx4↓, Iron↑, lipid-P↑, ROS↑, eff↓, TumCP↓, TumCD↑,
| - |
in-vitro, |
Cerv, |
INT-407 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, TumCMig↓, CTNNB1↓, Twist↓, Bcl-2↓, survivin↓, NF-kB↓, Sp1/3/4↓, BAX↑, P21↑, P53↑, eff↓, TumCMig↓,
Showing Research Papers: 1 to 10 of 10
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 10
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 2, Iron↑, 1, lipid-P↑, 1, ROS↑, 9, mt-ROS↑, 1, TrxR↓, 2, TrxR1↓, 1, TrxR2↓, 1, xCT↓, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, MMP↓, 3,
Cell Death ⓘ
p‑Akt↓, 1, Apoptosis↑, 5, mt-Apoptosis↑, 1, BAD↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp↑, 1, Casp3↑, 2, Casp9↑, 2, Cyt‑c↑, 1, Ferroptosis↑, 1, necrosis↑, 1, p27↑, 1, survivin↓, 1, TumCD↑, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
other∅, 1, tumCV↓, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, TFEB↑, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 2, P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 2, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
CTNNB1↓, 1, PI3K↓, 1, TumCG↓, 3,
Migration ⓘ
LAMP1?, 1, TumCMig↓, 2, TumCP↓, 2, Twist↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↓, 11, eff↑, 1, selectivity↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 3,
Total Targets: 52
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1,
Total Targets: 2
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page